Rapid development of secondary sclerosing cholangitis due to vancomycin-resistant enterococci
Summary
Secondary sclerosing cholangitis is a rare complication of acute bacterial cholangitis. The natural course of the disease is a slow progression over years. Here we report about a patient in whom sclerosing cholangitis evolved much faster as a consequence of a persistent biliary infection with vancomycin-resistant enterococci. The infection could be treated successfully with prolonged therapy with linezolid and teicoplanin. This is the first report of sclerosing cholangitis caused by vancomycin-resistant enterococci. It illustrates the rapidity with which this disease can evolve as a fulminant and ultimately fatal complication of acute bacterial cholangitis.
Keywords: Acute bacterial cholangitis, Secondary sclerosing cholangitis, Vancomycin-resistant enterococci, Linezolid
To access this article, please choose from the options below
PII: S0163-4453(06)00143-5
doi:10.1016/j.jinf.2006.04.004
© 2006 The British Infection Society. Published by Elsevier Inc. All rights reserved.
